v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Total
Private Placement
At-The-Market Offering
Common Stock, Pre-Funded Warrants, and Common Warrants
 [1]
Preferred Stock
Common Stock
Class A
Common Stock
Class A
Private Placement
Common Stock
Class A
At-The-Market Offering
Common Stock
Class A
Common Stock, Pre-Funded Warrants, and Common Warrants
 [1]
Common Stock
Class C
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
At-The-Market Offering
Additional Paid-In Capital
Common Stock, Pre-Funded Warrants, and Common Warrants
 [1]
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023         0 24,410,075       3,213,678          
Beginning balance at Dec. 31, 2023 $ 10,434,042       $ 0 $ 2,441       $ 321 $ 72,644,419       $ (62,213,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon Credova Acquisition (in shares)           2,920,993                  
Issuance of common stock upon Credova Acquisition 14,137,606         $ 292         14,137,314        
Issuance of shares for consulting arrangement (in shares)           183,349                  
Issuance of common stock for consulting arrangement 887,409         $ 18         887,391        
Issuance of common stock (in shares)             1,981,483 7,813,931              
Issuance of common stock   $ 5,350,004 $ 33,949,791       $ 198 $ 782       $ 5,349,806 $ 33,949,009    
Share-based compensation 19,835,744                   19,835,744        
Issuance of common stock from Employee Stock Purchase Plan (in shares)           2,265,668                  
Issuance of common stock for fully vested restricted stock units (57,101)         $ 227         (57,328)        
Net loss (57,687,289)                           (57,687,289)
Ending balance (in shares) at Dec. 31, 2024         0 39,575,499       3,213,678          
Ending balance at Dec. 31, 2024 26,850,206       $ 0 $ 3,958       $ 321 146,746,355       (119,900,428)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock (in shares)               815,971 1,800,000            
Issuance of common stock     $ 1,203,244 $ 6,720,667       $ 82 $ 180       $ 1,203,162 $ 6,720,487  
Share-based compensation 10,774,457                   10,774,457        
Issuance of common stock from Employee Stock Purchase Plan (in shares)           3,995                  
Issuance of common stock from Employee Stock Purchase Plan (in shares)           2,297,174                  
Issuance of common stock for fully vested restricted stock units 0         $ 230         (230)        
Issuance of common stock for asset acquisition (in shares)           2,000,000                  
Issuance of common stock for asset acquisition 4,500,000         $ 200         4,499,800        
Net loss (36,611,668)                           (36,611,668)
Ending balance (in shares) at Dec. 31, 2025         0 46,492,639       3,213,678          
Ending balance at Dec. 31, 2025 $ 13,436,906       $ 0 $ 4,650       $ 321 $ 169,944,031       $ (156,512,096)
[1] Pre-funded warrants can be exercised for little consideration (an exercise price per share equal to $0.0001 per share), and 5,018,184 remain unexercised as of December 31, 2025